Literature DB >> 21544904

Concise review: putting a finger on stem cell biology: zinc finger nuclease-driven targeted genetic editing in human pluripotent stem cells.

Joseph Collin1, Majlinda Lako.   

Abstract

Human pluripotent stem cells (hPSCs) encompassing human embryonic stem cells and human induced pluripotent stem cells (hiPSCs) have a wide appeal for numerous basic biology studies and for therapeutic applications because of their potential to give rise to almost any cell type in the human body and immense ability to self-renew. Much attention in the stem cell field is focused toward the study of gene-based anomalies relating to the causative affects of human disease and their correction with the potential for patient-specific therapies using gene corrected hiPSCs. Therefore, the genetic manipulation of stem cells is clearly important for the development of future medicine. Although successful targeted genetic engineering in hPSCs has been reported, these cases are surprisingly few because of inherent technical limitations with the methods used. The development of more robust and efficient means by which to achieve specific genomic modifications in hPSCs has far reaching implications for stem cell research and its applications. Recent proof-of-principle reports have shown that genetic alterations with minimal toxicity are now possible through the use of zinc finger nucleases (ZFNs) and the inherent DNA repair mechanisms within the cell. In light of recent comprehensive reviews that highlight the applications, methodologies, and prospects of ZFNs, this article focuses on the application of ZFNs to stem cell biology, discussing the published work to date, potential problems, and future uses for this technology both experimentally and therapeutically.
Copyright © 2011 AlphaMed Press.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21544904     DOI: 10.1002/stem.658

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  30 in total

Review 1.  Recreating kidney progenitors from pluripotent cells.

Authors:  Minoru Takasato; Barbara Maier; Melissa H Little
Journal:  Pediatr Nephrol       Date:  2013-09-13       Impact factor: 3.714

Review 2.  Dissecting neural function using targeted genome engineering technologies.

Authors:  Patrick D Hsu; Feng Zhang
Journal:  ACS Chem Neurosci       Date:  2012-07-19       Impact factor: 4.418

Review 3.  Assessing the risks of genotoxicity in the therapeutic development of induced pluripotent stem cells.

Authors:  So Gun Hong; Cynthia E Dunbar; Thomas Winkler
Journal:  Mol Ther       Date:  2012-12-04       Impact factor: 11.454

Review 4.  Controlling gene networks and cell fate with precision-targeted DNA-binding proteins and small-molecule-based genome readers.

Authors:  Asuka Eguchi; Garrett O Lee; Fang Wan; Graham S Erwin; Aseem Z Ansari
Journal:  Biochem J       Date:  2014-09-15       Impact factor: 3.857

5.  Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient iPSCs After Genome Editing of the Sickle Point Mutation.

Authors:  Xiaosong Huang; Ying Wang; Wei Yan; Cory Smith; Zhaohui Ye; Jing Wang; Yongxing Gao; Laurel Mendelsohn; Linzhao Cheng
Journal:  Stem Cells       Date:  2015-05       Impact factor: 6.277

Review 6.  A cut above the rest: targeted genome editing technologies in human pluripotent stem cells.

Authors:  Mo Li; Keiichiro Suzuki; Na Young Kim; Guang-Hui Liu; Juan Carlos Izpisua Belmonte
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

Review 7.  Pluripotent stem cells and gene therapy.

Authors:  Pavel Simara; Jason A Motl; Dan S Kaufman
Journal:  Transl Res       Date:  2013-01-23       Impact factor: 7.012

8.  Zinc-finger nuclease enhanced gene targeting in human embryonic stem cells.

Authors:  Brigham J Hartley; Stewart A Fabb; Ben A L Finnin; John M Haynes; Colin W Pouton
Journal:  J Vis Exp       Date:  2014-08-23       Impact factor: 1.355

Review 9.  Gene correction in patient-specific iPSCs for therapy development and disease modeling.

Authors:  Yoon-Young Jang; Zhaohui Ye
Journal:  Hum Genet       Date:  2016-06-02       Impact factor: 4.132

10.  Zinc finger nuclease-expressing baculoviral vectors mediate targeted genome integration of reprogramming factor genes to facilitate the generation of human induced pluripotent stem cells.

Authors:  Rui-Zhe Phang; Felix Chang Tay; Sal-Lee Goh; Cia-Hin Lau; Haibao Zhu; Wee-Kiat Tan; Qingle Liang; Can Chen; Shouhui Du; Zhendong Li; Johan Chin-Kang Tay; Chunxiao Wu; Jieming Zeng; Weimin Fan; Han Chong Toh; Shu Wang
Journal:  Stem Cells Transl Med       Date:  2013-10-28       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.